MICHAEL DZIAGWA: Open Payments
NPI 1649623679 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 50 payments from 18 companies in 2025. Trend: 2023 $2,122 · 2024 $1,388 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $162 |
| Lilly USA, LLC | 5 | $102 |
| Phathom Pharmaceuticals, Inc. | 4 | $95 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Ardelyx, Inc. | 3 | $64 |
| Exact Sciences Corporation | 2 | $50 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $38 |
| Abbott Laboratories | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
Products named: VOQUEZNA, QULIPTA, MOUNJARO, TRELEGY ELLIPTA, IBSRELA, Cologuard Collection Kit, JARDIANCE, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
